LncRNA MEG3表达量与脂多糖诱导支气管上皮细胞增殖及凋亡和炎症因子分泌的关系
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:

2019年郴州市级重点研发及技术创新引导项目(zdfy1959)


Relationship between LncRNA MEG3 expression and lipopolysaccharide-induced bronchial epithelial cell proliferation, apoptosis, and inflammatory factor secretion
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    【摘要】 目的 探讨长链非编码RNA母系表达基因3(LncRNA MEG3)对脂多糖(LPS)诱导的支气管上皮细胞增殖、凋亡及炎症因子分泌的影响。 方法 体外培养支气管上皮细胞16HBE,LPS处理16HBE细胞建立炎症损伤模型。采用酶联免疫吸附(ELISA)法检测白细胞介素-8(IL-8)与白细胞介素-1β(IL-1β)的含量;甲基噻唑基四唑(MTT)检测细胞增殖率;流式细胞术检测细胞凋亡率;实时荧光定量聚合酶链反应(qRT-PCR)检测LPS诱导的16HBE细胞中MEG3的表达水平。取对数生长期支气管上皮细胞,用50 μg/mL的LPS处理细胞24 h作为LPS组,正常培养的细胞作为NC组,将Si-MEG3、Si-con、pcDNA-MEG3、pcDNA转染主支气管上皮细胞48 h,随后使用50 μg/mL的LPS处理细胞24 h,分别命名为LPS+si-MEG3组、LPS+si-con组、LPS+pcDNA-MEG3组、LPS+pcDNA组。通过MTT与流式细胞术检测细胞增殖能力及凋亡能力的改变;蛋白免疫印迹法(Western blot)检测活化的含半胱氨酸的天冬氨酸蛋白水解酶3(Cleaved caspase-3)、活化的含半胱氨酸的天冬氨酸蛋白水解酶9(Cleaved caspase-9)、细胞周期蛋白1(CyclinD1)的蛋白表达量。 结果 与NC组相比,LPS组IL-8、IL-1β水平、细胞凋亡率及Cleaved caspase-3、Cleaved caspase-9蛋白的表达水平均显著升高(P<0.05),细胞增殖率及CyclinD1蛋白、MEG3的表达水平均显著降低(P<0.05);干扰MEG3表达可促进LPS诱导的支气管上皮细胞凋亡及抑制细胞增殖,与LPS+si-con组相比,LPS+si-MEG3组支气管上皮细胞中MEG3的表达水平、细胞增殖率、CyclinD1蛋白相对表达量显著降低(P<0.05),IL-8、IL-1β水平、细胞凋亡率、Cleaved caspase-3、Cleaved caspase-9蛋白相对表达量显著升高(P<0.05);与LPS+pcDNA组相比,LPS+pcDNA-MEG3组支气管上皮细胞中IL-8、IL-1β水平、细胞凋亡率及Cleaved caspase-3、Cleaved caspase-9蛋白的相对表达水平均显著降低(P<0.05),MEG3的表达水平、细胞增殖率及CyclinD1的表达水平均显著升高(均P<0.05)。 结论 LncRNA MEG3过表达能够促进LPS诱导的支气管上皮细胞增殖,抑制细胞凋亡,减少炎症因子分泌。

    Abstract:

    【Abstract】 Objective To investigate the effects of LncRNA MEG3 on LPSinduced bronchial epithelial cell proliferation, apoptosis and inflammatory factor secretion. Methods 16HBE cells were cultured in vitro, and the inflammatory injury model was established by LPS treatment. The contents of interleukin-8 (IL-8) and interleukin-1β (IL-1β) were determined by enzyme linked immunosorbent assay (ELISA). MTT was used to detect the cell proliferation rate. The apoptosis rate was detected by flow cytometry. The expression of meg3 in 16HBE cells induced by LPS was detected by QRT-PCR. The logarithmic growth phase bronchial epithelial cells were treated with 50 μg/mL LPS for 24 hours as LPS group, and normal cultured cells as NC group. The main bronchial epithelial cells were transfected with Si-MEG3, Si-con and pcNDA for 48 hours, then treated with 50 μg/mL LPS for 24 hours. They were named as LPS+Si-MEG3 group, LPS+Si-CON group, LPS+pcDNA-meg3 group and LPS+pcDNA group, respectively. MTT and flow cytometry were used to detect the changes of cell proliferation and apoptosis. Western blot was used to detect the protein expression of activated caspase 3, cleaved caspase 9 and cyclin D1. Results The levels of IL-8, IL-1β,apoptosis rate and the expression of cleaved caspase-3, cleaved caspase-9 in LPS group were significantly higher than those in NC group (P<0.05). Compared with NC group, the cell proliferation rate and the expression levels of cyclin D1 and meg3 were significantly decreased (P<0.05). The expression level of meg3, the cell proliferation rate and the relative expression of cyclin D1 in the LPS+si-MEG3 group were significantly lower than those in the LPS+si-CON group (P<0.05). Compared with the LPS+si-CON group, the levels of IL-8, IL-1β, apoptotic rate, relative expression of cleaved caspase-3 and cleaved caspase-9 were significantly increased (P<0.05). The levels of IL-8, IL-1β, apoptosis rate and the relative expression levels of cleaved caspase-3 and cleaved caspase-9 in the LPS+pcDNA-meg3 group were significantly lower than those in the LPS+pcDNA group (P<0.05). Compared with the LPS+pcDNA group, the expression levels of meg3, cell proliferation and cyclin D1 were significantly increased (all P<0.05). Conclusion Overexpression of LncRNA MEG3 promotes LPSinduced bronchial epithelial cell proliferation, inhibits apoptosis, and reduces inflammatory factor secretion. 

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2021-02-02
您是第位访问者
网站版权所有:《西部医学》编辑部     蜀ICP备18038379号-4
地址:四川省成都市武侯区小天竺街75号财富国际18F-1号    邮政编码:610041
电话:028-85570072/85588403 本网站支持 IPv6    E-mail:xbyxqk@163.com
技术支持:北京勤云科技发展有限公司